Treatment of Alcoholic Hepatitis
|
|
- Godwin Turner
- 5 years ago
- Views:
Transcription
1 REVIEW REVIEW Treatment of Alcoholic Hepatitis Timothy R. Morgan, M.D.,*, Daniel Chao, M.D,*, Gregory Botwin, M.D. Three steps must be completed before starting treatment for alcoholic hepatitis (AH). First, the diagnosis of alcoholic hepatitis must be made based on history and clinical and/or histological data. Second, the severity of AH must be determined using Maddrey s discriminant function, the model for endstage liver disease, 1 the Glasgow alcoholic hepatitis score, 2 or the ABIC (albumin-bilirubin-inr-creatinine) score. 3 These scores determine whether a patient should be treated (except ABIC), and the short-term prognosis. Finally, patients need to be assessed for infection with chest X-ray, blood cultures, urinalysis (preferably culture), and paracentesis (cell count and preferably Gram stain and culture). Approximately 25% of patients are infected at the time of hospital admission, and an additional 25% become infected while receiving treatment. 4 Abstinence Abstinence is critical to long-term survival. We recommend discussing abstinence with the patient and referral to an addiction specialist. We leave the decision about the use of drugs to reduce craving (e.g., baclofen, acamprosate, or naloxone) to the addiction specialist. However, use of these agents in patients with severe AH is not recommended due to risk of hepatotoxicity. Patients who return to drinking risk recurrence. Nutrition All patients with severe AH are malnourished. 5 Although nutritional treatment has not been proven to improve survival, 6 failure to consume sufficient calories is a marker of poor survival among patients with AH and severe malnutrition. 7 We use the guidelines shown in Table 1 for nutritional support. 8 Enteral feeding can be used in anorexic patients. Fifty milligrams of elemental zinc with meals may improve gut barrier function. 9 Drug Treatment Prednisolone. Prednisolone at 40 mg/day for 28 days with or without a 2-week taper is the recommended treatment by the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver 10,11 but was judged to be ineffective in improving overall or liver-related survival by the Cochran Reviews 12 (Fig. 1). Patients suitable for treatment are those with a discriminant function >32 or with hepatic encephalopathy (Table 2). Exclusions include recent (i.e., past 2-4 days) upper gastrointestinal bleeding, uncontrolled diabetes, or significant renal insufficiency. Patients with infection can be treated after the infection has been controlled with antibiotics for several days. Patients with hepatitis C or hepatitis B (controlled with drugs) can receive prednisolone. We agree with the AASLD s recommendation of prednisolone treatment for 28 days 11 among patients with severe AH. Many hepatologists assess response to prednisolone treatment using the Lille score ( which measures baseline prognostic markers as well as biochemical response to prednisolone after 7 days of therapy. 13 Patients with a Lille score <0.45 should continue prednisolone treatment for a total of 28 days, because prednisolone treatment improves survival in this subset of patients. There is debate regarding the management of patients with a Lille score 0.45 (poor response to prednisolone). In their initial evaluation, Louvet and colleagues 13 suggested that prednisolone be discontinued among patients with a Lille score 0.45, whereas their recent report, based on a larger sample and alternative cut points, suggests that patients with a Lille score 0.56 are unlikely to benefit from prednisolone. 14 Our suggestion is to consider discontinuing prednisolone in patients with Lille score Abbreviations: AASLD, American Association for the Study of Liver Diseases; ABIC, albumin-bilirubin-inr-creatinine; AH, alcoholic hepatitis; NAC, N- acetylcysteine; PTX, pentoxifylline. *Gastroenterology Section and Research Service, VA Long Beach Healthcare System, Long Beach, CA; and the Division of Gastroenterology, University of California, Irvine, CA Potential conflict of interest: Nothing to report. View this article online at wileyonlinelibrary.com VC 2012 by the American Association for the Study of Liver Diseases doi: /cld Clinical Liver Disease, Vol. 2, No. 2, April 2013 An Official Learning Resource of AASLD
2 Pentoxifylline. Orally administered pentoxifylline (PTX) at 400 mg thrice daily for 28 days is an alternative treatment for severe AH. 11 There are no absolute contraindications to PTX treatment. In the initial study of 101 patients, PTX improved survival by decreasing the incidence of hepatorenal syndrome. 15 Subsequent trials with PTX have been smaller but have confirmed improved outcomes with PTX treatment. The Cochran Review concluded that PTX reduced mortality by approximately 35%, with seven patients needed to be treated to save the life of one patient 16 (Fig. 2). TABLE 1: Recommended Nutritional Treatment for AH Calories cal/kg/day Protein g/kg/day Sodium 2 g/day Meals 4 or 5 meals per day, including an evening snack Multivitamins, Thiamine, B 2,B 12, folate, minerals magnesium, zinc, selenium Calories and protein are given according to ideal body weight. Treatment of Nonresponders There is uncertainty regarding appropriate treatment of patients who do not respond to prednisolone (Lille score 0.45 or 0.56) or PTX (vaguely defined). Analysis of retrospective databases suggests that switching poorly responding patients from prednisolone to PTX does not improve survival. 17 A randomized controlled trial that was presented at the AASLD annual meeting in 2011 but is not yet published showed that combination treatment with prednisolone and PTX was not better than treatment with prednisolone alone: the 6-month survival (68%) and the incidence of hepatorenal syndrome (10%) was similar in both groups. 18 Not only does this trial suggest that combination treatment is not better than prednisolone alone, it also suggests that PTX alone is not better than prednisolone alone. Thus, at the current time, there is no evidence that adding a second drug, or switching to the alternative treatment, is beneficial for patients who respond poorly to their initial treatment. TABLE 2: Inclusion and Exclusion Criteria for Treatment of AH Inclusion Severity of liver disease Hepatic encephalopathy Exclusion Infection uncontrolled by antibiotics Recent upper gastrointestinal bleeding Hepatorenal syndrome Uncontrolled diabetes Uncontrolled hepatitis B Human immunodeficiency virus FIGURE 1. Meta-analysis of survival among subjects receiving prednisolone or placebo grouped according to the inclusion criteria used in the clinical trial. Prednisolone treatment was associated with improved survival in trials that enrolled subjects with Maddrey s discriminant function >31 or hepatic encephalopathy, but not in clinical trials that used other inclusion criteria nor when all trials were combined. Reprinted with permission from Alimentary Pharmacology & Therapeutics. 12 Wiley- Blackwell, Clinical Liver Disease, Vol. 2, No. 2, April 2013 An Official Learning Resource of AASLD
3 FIGURE 2. Meta-analysis of survival among subjects receiving PTX or placebo. Reprinted with permission from: The Cochrane Database of Systematic Reviews. 16 Wiley, recent study by Nguyen-Khac et al., 22 in which NAC was given intravenously for 5 days in combination with prednisolone, suggest that NAC may be beneficial. 22 In this study, 174 patients were randomized to prednisolone þ placebo (intravenous saline) or prednisolone þ NAC for 5 days, followed by prednisolone for the next 23 days. Mortality at 1 month was better in the NAC þ prednisolone arm (8%) compared with the prednisolone alone arm (24%) (P < 0.006). The primary outcome of the trial, however, was 6-month mortality that was similar in the NAC þ prednisolone arm (27%) and the prednisolone alone arm (38%) (P ¼ 0.07) (Fig. 3). Although this trial suggests that NAC may improve survival, given the lack of efficacy with antioxidant therapy in prior clinical trials, our opinion is that additional clinical trials are needed before NAC can be recommended for treatment of AH. FIGURE 3. Six-month survival among patients with AH randomized to receive 28 days of prednisolone or 28 days of prednisolone and 5 days of intravenous NAC. Reprinted with permission from The New England Journal of Medicine. 22 Boston, Massachusetts Medical Society, Are antioxidants the Answer? There is widespread acceptance that AH is a condition of excessive oxidative stress. Three clinical trials published prior to 2011 using a variety of antioxidant cocktails, including N- acetylcysteine (NAC), reported no difference in survival when compared with enteral nutrition, 19 worse survival when compared with prednisolone, 20 and no improvement in survival when added to prednisolone. 21 However, the results of a Liver Transplantation, the Next Frontier Patients with a Lille score >0.45 have a 70% mortality by 6 months, 13 the usual amount of time a patient needs to be abstinent before considering liver transplantation. Consequently, Mathurin et al. 23 conducted a clinical trial of liver transplantation in highly selected patients who failed prednisolone treatment. The enrolled patients had no prior history of alcoholic liver disease (first episode), had a supportive family, and were deemed acceptable candidates by their primary medical team (residents and attending physician), an addiction specialist, their hepatologists, and their surgical team (anesthesiologist and surgeon). A total of 26 patients were placed on the liver transplantation list an average of 13 days after hospital admission. Survival among patients receiving liver transplantation (77% at 6 months) was significantly higher than predicted survival (30%) (P < 0.001) and only slightly less than estimated survival among patients with a Lille score < 0.45 (85%) (P ¼ 0.33) (Fig. 4). Approximately 2% of patients with AH at the participating hospitals 86 Clinical Liver Disease, Vol. 2, No. 2, April 2013 An Official Learning Resource of AASLD
4 FIGURE 4. Kaplan-Meier estimates of survival among 26 subjects with AH undergoing liver transplantation and randomly selected matched control subjects failing to respond to prednisolone (Lille score 0.45) and responding to prednisolone (Lille score <0.45). Reprinted with permission from The New England Journal of Medicine. 23 Boston, Massachusetts Medical Society, qualified for liver transplantation, and 3% of liver transplantations performed at the hospitals were for patients with AH. Three patients returned to drinking, but only one to harmful levels. No patient needed retransplantation. These investigators continue to perform liver transplantation for highly selected patients as part of a clinical trial. Early liver transplantation for AH is not generally accepted among liver transplantation centers in the United States. The Future Clinical trials are underway in Europe comparing prednisolone with PTX and comparing prednisolone with prednisolone þ NAC. Transplantation centers in the United States are beginning to discuss liver transplantation for AH. Recently, the National Institute on Alcohol Abuse and Alcoholism has funded two consortia to evaluate new treatments for AH. The clinical trials in these consortia, as well as the detailed study of pathophysiology of liver injury that is obtained in conjunction with these trials, should provide critical data for the identification of future treatments. CORRESPONDENCE Timothy Morgan, Gastroenterology Section, VA Long Beach Healthcare System, 5901 E. Seventh Street 11, Long Beach, CA timothy.morgan@va.gov References 1. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: Forrest EH, Morris AJ, Stewart S, Phillips M, Oo YH, Fisher NC, et al. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut 2007;56: Dominguez M, Rincon D, Abraldes JG, Miquel R, Colmenero J, Bellot P, et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol 2008;103: Louvet A, Wartel F, Castel H, Dharancy S, Hollebecque A, Canva-Delcambre V, et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 2009;137: Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, et al. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr 1995;19: Koretz RL, Avenell A, Lipman TO.Nutritional support for liver disease. Cochrane Database Syst Rev 2012;5:CD Mendenhall C, Roselle GA, Gartside P, Moritz T.Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res 1995;19: Plauth M, Cabre E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006;25: Mohammad MK, Zhou Z, Cave M, Barve A, McClain CJ.Zinc and liver disease. Nutr Clin Pract 2012;27: Mathurin P, Lucey MR.Management of alcoholic hepatitis. J Hepatol 2012; 56(suppl 1):S39 S O shea RS, Dasarathy S, McCullough AJ.Alcoholic liver disease. Hepatology 2010;51: Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C.Systematic review: glucocorticosteroids for alcoholic hepatitis a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther 2008;27: Clinical Liver Disease, Vol. 2, No. 2, April 2013 An Official Learning Resource of AASLD
5 13. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007;45: Mathurin P, O Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2011;60: Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O.Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a doubleblind, placebo-controlled trial. Gastroenterology 2000;119: Whitfield K, Rambaldi A, Wetterslev J, Gluud C.Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev 2009:7;CD Louvet A, Diaz E, Dharancy S, Coevoet H, Texier F, Thevenot T, et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol 2008;48: Mathurin P, Louvet A, Dao T, Nahon P, Diaz E, Carbonell N, et al. Addition of pentoxifylline to prednisolone for severe alcoholic hepatitis does not improve 6-month survival: results of the Corpentox trial. Hepatology 2011; Moreno C, Langlet P, Hittelet A, Lasser L, Degre D, Evrard S, et al. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. J Hepatol 2010; 53: Phillips M, Curtis H, Portmann B, Donaldson N, Bomford A, O Grady J.Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis a randomised clinical trial. J Hepatol 2006;44: Stewart S, Prince M, Bassendine M, Hudson M, James O, Jones D, et al. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol 2007;47: Nguyen-Khac E, Thevenot T, Piquet MA, Benferhat S, Goria O, Chatelain D, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med 2011;365: Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011; 365: Clinical Liver Disease, Vol. 2, No. 2, April 2013 An Official Learning Resource of AASLD
Therapeutic Strategy in Severe Alcoholic Hepatitis: Present to future development of New
Therapeutic Strategy in Severe Alcoholic Hepatitis: Present to future development of New Philippe Mathurin Service Maladies de l Appareil Digestif Inserm U995 Hôpital Claude Huriez Lille France molecules
More informationPrednisolone or Pentoxifylline for Alcoholic Hepatitis
The new england journal of medicine Original Article Prednisolone or Pentoxifylline for Alcoholic Hepatitis Mark R. Thursz, M.D., Paul Richardson, M.D., Michael Allison, Ph.D., Andrew Austin, M.D., Megan
More informationIndian Journal of Basic and Applied Medical Research; June 2017: Vol.-6, Issue- 3, P
Original article: Study of usefulness of Discriminant Function (DF) and Glasgow Alcoholic Hepatitis Score (GAHS) in treatment of patients of Alcoholic Hepatitis in Indian Population Dr Mugdha Thakur, Dr
More informationOVERVIEW OF ALD ALCOHOLIC LIVER DISEASE DISCLOSURE
ALCOHOLIC LIVER DISEASE KEVIN D MULLEN MD West Virginia University Morgantown WV DISCLOSURE I have nothing to disclose. AMOUNT OF ALCOHOL PER STANDARD DRINK > (30 ) GRAM OF ALCOHOL PER DAY USA Canada UK
More informationAlcoholic Hepatitis: Management Options
Alcoholic Hepatitis: Management Options Paul J. Thuluvath, MD. FRCP Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore Professor of Surgery & Medicine, Georgetown University,
More informationAlcoholic Hepatitis. Christian Doppler Research Laboratory for Gut Inflammation Medical University Innsbruck. Herbert Tilg
Alcoholic Hepatitis Christian Doppler Research Laboratory for Gut Inflammation Medical University Innsbruck Herbert Tilg Overview Background I: Alcoholic steatohepatitis (ASH) is a severe and often life-threatening
More informationAlcoholic Hepatitis: Routine Screening for Early Recognition and Management. Juan Guerrero, MD
Alcoholic Hepatitis: Routine Screening for Early Recognition and Management Juan Guerrero, MD Global Problem 1% of GNP of medium/high income countries Additional societal costs Disproportionately affects
More informationPaul Martin, MD, FACG. University of Miami. 30,000 deaths from cirrhosis per annum, alcohol implicated in 48%
Paul Martin, MD, FACG University of Miami 30,000 deaths from cirrhosis per annum, alcohol implicated in 48% Second commonest indication for liver transplant NIAA 2007 Page 1 of 26 Risk Factors Medical
More informationAlcoholic hepatitis: an update for best practice
Page 1 of 10 Chronic Hepatitis Alcoholic hepatitis: an update for best practice PJ Parekh, R Shams, MJ Ryan, DA Johnson* Abstract Introduction Alcoholic hepatitis, with its significant associated morbidity
More informationA lcoholic hepatitis is perhaps the most florid manifestation
1174 ALCOHOLIC LIVER DISEASE Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score E H Forrest, C D J Evans, S Stewart,
More informationPrognostic models for alcoholic hepatitis
Rahimi and Pan Biomarker Research (2015) 3:20 DOI 10.1186/s40364-015-0046-z REVIEW Prognostic models for alcoholic hepatitis Erik Rahimi * and Jen-Jung Pan Open Access Abstract Alcoholic hepatitis (AH)
More informationManagement of alcoholic hepatitis: Implications for options beyond the STOPAH study
Management of alcoholic hepatitis: Implications for options beyond the STOPAH study Gyongyi Szabo, MD, PhD Professor University of Massachusetts Medical School Worcester, MA Cape Town, South Africa 2015
More informationAlcoholic hepatitis (AH) is an acute, inflammatory. MELD Accurately Predicts Mortality in Patients With Alcoholic Hepatitis
MELD Accurately Predicts Mortality in Patients With Alcoholic Hepatitis Winston Dunn, 1 Laith H. Jamil, 1 Larry S. Brown, 2 Russell H. Wiesner, 1 W. Ray Kim, 1 K. V. Narayanan Menon, 1 Michael Malinchoc,
More informationAccepted Manuscript. Controversies in Hepatology. Controversies in Clinical Trials for Alcoholic Hepatitis
Accepted Manuscript Controversies in Hepatology Controversies in Clinical Trials for Alcoholic Hepatitis Sarah R. Lieber, John P. Rice, Michael R. Lucey, Ramon Bataller PII: S0168-8278(17)32325-5 DOI:
More informationALCOHOLIC LIVER DISEASE (ALD) Nayan Patel, DO Transplant Hepatology/GI Banner Advanced Liver Disease and Transplant Center
ALCOHOLIC LIVER DISEASE (ALD) Nayan Patel, DO Transplant Hepatology/GI Banner Advanced Liver Disease and Transplant Center Objectives Spectrum of alcoholic liver disease Focus on Alcoholic Hepatitis (AH)
More informationAccepted Manuscript. S (18) DOI: /j.gastro Reference: YGAST 61873
Accepted Manuscript Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo a Meta-analysis of Individual Data Alexandre
More informationACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries Ashwani K. Singal, MD, MS, FACG 1, Ramon Bataller, MD, PhD, FACG 2, Joseph Ahn, MD, MS, FACG (GRADE Methodologist) 3, Patrick S. Kamath,
More informationPrise en charge de l hépatite alcoolique aiguë
Prise en charge de l hépatite alcoolique aiguë Prof Christophe Moreno M.D. Ph.D. Clinical Director, Liver Unit Dept. of Gastroenterology, Hepato-Pancreatology and Digestive Oncology CUB Hôpital Erasme
More informationAlcoholic hepatitis: A comprehensive review of pathogenesis and treatment
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v20.i20.6279 World J Gastroenterol 2014 May 28; 20(20): 6279-6286 ISSN 1007-9327 (print)
More informationA Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis
306 ORIGINAL CONTRIBUTIONS see related editorial on page x A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis Mauricio Garcia-Saenz-de-Sicilia, MD 1, 9,
More informationAmmonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis
Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality
More informationWhite cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers
Hardy et al. BMC Gastroenterology 2013, 13:55 RESEARCH ARTICLE Open Access White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers Timothy Hardy
More informationManagement of Alcoholic Liver Disease. Hafez Fakheri Professor of medicine, Sari, Iran
Management of Alcoholic Liver Disease Hafez Fakheri Professor of medicine, Sari, Iran Alcoholic Hepatitis Scores DF = (4.6 x [ PT- control PT]) + (bili ) MELD = 10 * ((0.957 * ln(cr)) + (0.378 * ln(bil))
More informationSteroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial
Forrest et al. Trials 2013, 14:262 TRIALS STUDY PROTOCOL Open Access Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial Ewan Forrest 1, Jane Mellor
More informationGlucocorticoids plus N-Acetylcysteine in Severe Alcoholic Hepatitis
original article Glucocorticoids plus N-Acetylcysteine in Severe Alcoholic Hepatitis Eric Nguyen-Khac, M.D., Ph.D., Thierry Thevenot, M.D., Marie-Astrid Piquet, M.D., Ph.D., Saïd Benferhat, M.D., Odile
More informationPrednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic Hepatitis A Randomized Clinical Trial
Research Original Investigation Prednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic Hepatitis A Randomized Clinical Trial Philippe Mathurin, MD; Alexandre Louvet,
More informationManagement of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL
Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL Terminology Acute decompensation of cirrhosis - stable patient with sudden deterioration Acute-on-chronic liver failure
More informationMishra et al., IJPSR, 2018; Vol. 9(5): E-ISSN: ; P-ISSN:
IJPSR (2018), Volume 9, Issue 5 (Research Article) Received on 11 August, 2017; received in revised form, 01 February, 2018; accepted, 11 March, 2018; published 01 May, 2018 PROGNOSTIC UTILITY OF LILLE
More informationESPEN Congress Madrid 2018
ESPEN Congress Madrid 2018 Nutrition In Solid Organ Transplant Patients Undernutrition In Transplant Patients O. Abbasoglu (TR) Undernutrition in Transplant Patients Dr. Osman Abbasoğlu Professor of Surgery,
More informationNutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis
Liver International ISSN 1478-3223 REVIEW ARTICLE Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis Annette D. Fialla 1, Mads Israelsen 1, Ole Hamberg 2, Aleksander
More informationREVIEW ARTICLE. Alcoholic Hepatitis Mitchell Padkins 1, Syed Hasan Naqvi 2
Alcoholic Hepatitis Mitchell Padkins 1, Syed Hasan Naqvi 2 1 University of Missouri School of Medicine. 2 Division of Hospital Medicine, Department of Medicine, University of Missouri, Columbia, Missouri
More informationLiver Transplant: Alcoholic liver disease as first indication
Monotematica AISF The future of liver disease: beyond HCV there is a role for hepatologist? Milano, 13-15 Ottobre 2016 Liver Transplant: Alcoholic liver disease as first indication Giacomo Germani Multivisceral
More informationAlcoholic liver disease is one of the top. Alcoholic hepatitis current concepts and management INTRODUCTION EPIDEMIOLOGY AND CLINICAL DATA
2 PRACTICA MEDICALÅ REFERATE GENERALE MD, Mircea MANUC Alcoholic hepatitis current concepts and management MIRCEA MANUC, MD, PhD; MIRCEA DICULESCU, Prof., MD, PhD Fundeni Clinical Institute, National Center
More informationAlcoholic hepatitis (AH), in its severe form, is associated
LIVER FAILURE AND LIVER DISEASE Early Change in Bilirubin Levels Is an Important Prognostic Factor in Severe Alcoholic Hepatitis Treated With Prednisolone Philippe Mathurin, 1,2 Marcelle Abdelnour, 3,5
More informationAlcoholic hepatitis (AH) is a severe clinical
HEPATOLOGY, VOL. 66, NO. 6, 2017 AMERICAN ASSOCIATION FOR THE STUDY OFLIVERD I S E ASES STEATOHEPATITIS/METABOLIC LIVER DISEASE Alcohol Abstinence in Patients Surviving an Episode of Alcoholic Hepatitis:
More informationTREATMENT OF PRIMARY BILIARY CIRRHOSIS (PBC)
TREATMENT OF PRIMARY BILIARY CIRRHOSIS (PBC) URSO not indicated Therapy for PBC Difficulties Etiology is uncertain Therapies are based on ideas regarding pathogenesis Present medical therapies have a limited
More informationAsignificant proportion of deaths from alcoholic. Theophylline Improves Steroid Sensitivity in Acute Alcoholic Hepatitis
Theophylline Improves Steroid Sensitivity in Acute Alcoholic Hepatitis Stuart F. W. Kendrick, Elsbeth Henderson, Jeremy Palmer, David E. J. Jones, and Chris P. Day Corticosteroid therapy has shown some
More informationWhat Is the Real Gain After Liver Transplantation?
LIVER TRANSPLANTATION 15:S1-S5, 9 AASLD/ILTS SYLLABUS What Is the Real Gain After Liver Transplantation? James Neuberger Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom;
More informationInfection does not increase long-term mortality in patients with acute severe alcoholic hepatitis treated with corticosteroids
Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2052 World J Gastroenterol 2017 March 21; 23(11): 2052-2059 ISSN 1007-9327 (print) ISSN 2219-2840 (online) ORIGINAL ARTICLE Observational
More informationALCOHOL ABSTINENCE IN PATIENTS SURVIVING AN EPISODE OF ALCOHOLIC HEPATITIS: PREDICTION AND IMPACT ON LONG-TERM SURVIVAL
ALCOHOL ABSTINENCE IN PATIENTS SURVIVING AN EPISODE OF ALCOHOLIC HEPATITIS: PREDICTION AND IMPACT ON LONG-TERM SURVIVAL José Altamirano 1,, Hugo López-Pelayo 2, Javier Michelena 1, Patricia D. Jones 5,
More informationTreatment with Metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis
ORIGINAL ARTICLE May-June, Vol. 13 No. 3, 2014: 343-352 Treatment with Metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis Fátima Higuera-de la Tijera,* Alfredo I.
More informationManagement of acute alcoholic hepatitis
Management of acute alcoholic hepatitis Yesim ALAHDAB Marmara University Hospital, Istanbul/TURKEY 5 th European Young Hepatologists Workshop August, 27-29, 2015 Moulin de Vernègues, France 1.4L ALCOHOL
More informationConflicts of Interest in the last 12 months
STEATOHEPATITIS Richard K. Sterling, MD, MSc, FACP, FACG VCU Hepatology Professor of Medicine Chief, Section of Hepatology Virginia Commonwealth University Richmond, VA Conflicts of Interest in the last
More informationACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, M.D., 1 Arun J. Sanyal, M.D., 2 Norman D. Grace,
More informationA PROSPECTIVE OBSERVATIONAL STUDY ON EFFECTS OF HEPATOPROTECTIVE AGENTS IN ALCOHOLIC LIVER DISEASE AT A TERTIARY CARE HOSPITAL
Available online on 15.01.2018 at http://jddtonline.info Journal of Drug Delivery and Therapeutics Open Access to Pharmaceutical and Medical Research 2011-17, publisher and licensee JDDT, This is an Open
More informationREVIEW. Ariel W. Aday, M.D.,* Nicole E. Rich, M.D.,* Arjmand R. Mufti, M.D., and Shannan R. Tujios, M.D.
REVIEW CON ( The Window Is Closed ): In Patients With Cirrhosis With Ascites, the Clinical Risks of Nonselective beta-blocker Outweigh the Benefits and Should NOT Be Prescribed Ariel W. Aday, M.D.,* Nicole
More informationThe management of alcoholic liver disease
Journal of Hepatology 38 (2003) S2 S13 www.elsevier.com/locate/jhep The management of alcoholic liver disease Stephen F. Stewart, Christopher P. Day* Centre for Liver Research, Medical School, Framlington
More informationAlcoholic Hepatitis To Transplant or Not To Transplant, That is the Question
Alcoholic Hepatitis To Transplant or Not To Transplant, That is the Question Arjmand Mufti, MD, MRCP (UK) Division of Digestive and Liver Diseases University of Texas Southwestern Medical Center Internal
More informationAlcoholic Liver Disease Strategies for Seamless Care or An Clinical Approach to the Jaundiced Alcoholic Patient
Alcoholic Liver Disease Strategies for Seamless Care or An Clinical Approach to the Jaundiced Alcoholic Patient Liver Disease for the General Physician Royal College of Physicians July 2017 Dr Ewan Forrest
More informationEarly Liver Transplantation for Severe Alcoholic Hepatitis in the United States A Single-Center Experience
American Journal of Transplantation 2016; 16: 841 849 Wiley Periodicals Inc. Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1111/ajt.13586
More informationPresentation and mortality of primary biliary cirrhosis in older patients
Age and Ageing 2000; 29: 305 309 Presentation and mortality of primary biliary cirrhosis in older patients JULIA L. NEWTON 1,DAVID E. JONES 2,JANE V. METCALF 2,JAY B. PARK 2,ALISTAIR D. BURT 2, MARGARET
More informationGlucocorticosteroids for people with alcoholic hepatitis (Review)
Cochrane Database of Systematic Reviews Glucocorticosteroids for people with alcoholic hepatitis (Review) Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C Pavlov CS, Varganova DL,
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationThe MELD Score in Advanced Liver Disease: Association with Clinical Portal Hypertension and Mortality
The MELD Score in Advanced Liver Disease: Association with Clinical Portal Hypertension and Mortality Sammy Saab, 1,2 Carmen Landaverde, 3 Ayman B Ibrahim, 2 Francisco Durazo, 1,2 Steven Han, 1,2 Hasan
More informationContraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:
Contraindications Absolute Relative Primary prevention variceal bleeding HCC if centrally located Active congestive heart failure Obstruction all hepatic veins Thomas D. Boyer, M.D. University of Arizona
More informationInt J Clin Exp Med 2016;9(6): /ISSN: /IJCEM
Int J Clin Exp Med 2016;9(6):10364-10373 www.ijcem.com /ISSN:1940-5901/IJCEM0023853 Original Article Early bilirubin response in acute-on-chronic hepatitis B liver failure patients treated with corticosteroids
More informationNutrition Management of End- Stage Liver Failure
Nutrition Management of End- Stage Liver Failure Krystel Ouaijan, RDN, MSc Nutrition Support Dietitian in Saint George Hospital UMC PhD in University of Geneva Just few questions https://www.mentimeter.com/s/c1c1be18dc2
More informationThe pediatric end-stage liver disease (PELD) score
Selection of Pediatric Candidates Under the PELD System Sue V. McDiarmid, 1 Robert M. Merion, 2 Dawn M. Dykstra, 2 and Ann M. Harper 3 Key Points 1. The PELD score accurately predicts the 3 month probability
More informationExtracorporeal liver support in severe alcoholic hepatitis
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v20.i25.8011 World J Gastroenterol 2014 July 7; 20(25): 8011-8017 ISSN 1007-9327 (print)
More informationManagement of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy
Management of Ascites and Hepatorenal Syndrome Florence Wong University of Toronto June 4, 2016 6/16/2016 1 Disclosures Gore & Associates: Consultancy Sequana Medical: Research Funding Mallinckrodt Pharmaceutical:
More informationCritical care and cirrhosis: outcome and benefit Julia Wendon, William Bernal, Chris Willars and Georg Auzinger
Critical care and cirrhosis: outcome and benefit Julia Wendon, William Bernal, Chris Willars and Georg Auzinger Institute of Liver Studies, Kings College Hospital, Denmark Hill, London, UK Correspondence
More informationORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:65 71 ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT Acute Kidney Injury Is an Early Predictor of Mortality for Patients With Alcoholic Hepatitis
More informationNutritional Issues In Advanced Liver Disease. Corrie Clark, RDN, LD
Nutritional Issues In Advanced Liver Disease Corrie Clark, RDN, LD Objectives List specific points to keep in mind when assessing the nutritional status of patients with advanced liver disease. Describe
More informationARTIGO ORIGINAL / ORIGINAL ARTICLE
ARTIGO ORIGINAL / ORIGINAL ARTICLE DOI: 10.1590/S0004-28032015000100006 USEFULNESS OF A NEW PROGNOSTIC INDEX FOR ALCOHOLIC HEPATITIS INTRODUCTION Alcohol abuse represents a situation of expressive morbimortality
More informationAlcoholic hepatitis: How far are we and where are we going?
CONCISE REVIEW July-August, Vol. 15 No. 4, 2016: 463-473 463 The Official Journal of the Mexican Association of Hepatology, the Latin-American Association for Study of the Liver and the Canadian Association
More informationVIRAL HEPATITIS. Definitions. Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Acute Viral Hepatitis Symptoms
Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Definitions AST and ALT Markers of hepatocellular injury Ryan M. Ford, MD Assistant Professor of Medicine Director of Viral Hepatitis
More informationTherapies for Idiopathic Pulmonary Fibrosis Pharmacologic, Non-Pharmacologic
Therapies for Idiopathic Pulmonary Fibrosis Pharmacologic, Non-Pharmacologic Amy Olson, MD, MSPH Associate Professor, Division of Pulmonary and Critical Care Medicine National Jewish Health, Denver, CO
More informationAlcoholism and Alcohol Liver Disease from a Transplant Hepatology Perspective
Alcoholism and Alcohol Liver Disease from a Transplant Hepatology Perspective Clark Kulig, MD Director, Porter Center for Liver Care Denver, CO February 2015 Does quantity of alcohol correlate with liver
More informationVirtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:
Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12: 805-809. CLINICAL PEARL Indications for Use of TIPS in Treating Portal Hypertension Elizabeth C. Verna,
More informationPredictors of hepatorenal syndrome in alcoholic liver cirrhosis
Predictors of hepatorenal syndrome in alcoholic liver cirrhosis Martin Janicko, Eduard Veseliny, Gabriela Senajova, Peter Jarcuska Background. Alcoholic liver disease is a major cause of liver cirrhosis
More informationManagement of Alcoholic Hepatitis
Management of Alcoholic Hepatitis Richard K. Sterling, MD, MSc, FACP, FACG, FAASLD, AGAF VCU Hepatology Professor of Medicine Chief, Section of Hepatology Program Director, Transplant Hepatology Virginia
More informationEuropean. Young Hepatologists Workshop. Organized by : Quantification of fibrosis and cirrhosis outcomes
supported by from Gilea Quantification of fibrosis and cirrhosis outcomes th 5 European 5 European Young Hepatologists Workshop Young Hepatologists Workshop August, 27-29. 2015, Moulin de Vernègues Vincenza
More informationObjectives. Pathophysiology of Steroids. Question 1. Pathophysiology 3/1/2010. Steroids in Septic Shock: An Update
Objectives : An Update Michael W. Perry PharmD, BCPS PGY2 Critical Care Resident Palmetto Health Richland Hospital Review the history of steroids in sepsis Summarize the current guidelines for steroids
More informationLiver Transplantation for Alcoholic Liver Disease: A Survey of Transplantation Programs in the United States
Liver Transplantation for Alcoholic Liver Disease: A Survey of Transplantation Programs in the United States James E. Everhart* and Thomas P. Beresford A lcoholic liver disease (ALD) is one of the most
More informationA lcoholic liver disease (ALD) refers to a. Food for Thought: Importance of Nutrition in Alcoholic Hepatitis
Carol Rees Parrish, M.S., R.D., Series Editor Food for Thought: Importance of Nutrition in Alcoholic Hepatitis Ariel W. Aday Mack C. Mitchell As alcohol consumption increases worldwide, so does the prevalence
More informationHepatology on the AMU
Hepatology on the AMU RCP day, 8 th February 2018 Jo Leithead Consultant in Hepatology and Liver Transplantation Addenbrookes Hospital Cambridge Is liver disease relevant to me? Williams R, Lancet 2014
More informationKing s College Hospital NHS Foundation Trust. Acute on Chronic Liver Failure: Practical management outside the tertiary centre.
King s College Hospital NHS Foundation Trust NHS Acute on Chronic Liver Failure: Practical management outside the tertiary centre. William Bernal Professor of Liver Critical Care Liver Intensive Therapy
More informationPredicting utility of a model for end stage liver disease in alcoholic liver disease
PO Box 2345, Beijing 00023, China World J Gastroenterol 2006 July 7; 2(25): 4020-4025 World Journal of Gastroenterology ISSN 007-9327 wjg@wjgnet.com 2006 The WJG Press. All rights reserved. CLINICAL RESEARCH
More informationNCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease
NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease Hospital Number Admission to hospital 5. Trusts should ensure that medical patients are reviewed by a consultant
More informationUNIVERSITY OF CALGARY. Jack X.Q. Pang A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE
UNIVERSITY OF CALGARY Epidemiology and Outcomes of Alcoholic Hepatitis in Calgary: A Population-based Study by Jack X.Q. Pang A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT
More informationAlcoholic Hepatitis: A review with emphasis on liver transplantation and alternative medical treatment
Review articles Alcoholic Hepatitis: A review with emphasis on liver transplantation and alternative medical treatment David Ríos P, MD 1, Dariana Pereira R, MD 1, Juan Carlos Restrepo G, MD 2 1 Surgeon,
More informationManagement of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France
Management of autoimmune hepatitis Pierre-Emmanuel RAUTOU Inserm U970, PARCC@HEGP, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France 41 year-old woman, coming to emergency department for fatigue
More informationDeveloped for Scotland by the National Plasma Product Expert Advisory Group. Clinical Guidelines for Human Albumin Use
Approved by NPPEAG 28 May 2018 Reviewed 1 June 2018 To be reviewed 1 June 2020 Developed for Scotland by the National Plasma Product Expert Advisory Group Clinical Guidelines for Human Albumin Use 1 National
More informationForward-looking Statements
Forward-looking Statements This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding
More information4/3/2014. Elizabeth Thompson, PharmD April Understand the importance of the liver and basic physiology.
Liver Disease Elizabeth Thompson, PharmD thompse@sarmc.org April 2014 Objectives Understand the importance of the liver and basic physiology. Review hepatic disorders Recognize liver function scoring systems
More informationEsophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph
Esophageal Varices Beta-Blockers or Band Ligation Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation? Risk of esophageal variceal
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES
Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of
More informationComprehensive Review of Alcoholic Liver Disease
Human Journals Review Article April 2018 Vol.:12, Issue:1 All rights are reserved by Qadrie ZL et al. Comprehensive Review of Alcoholic Liver Disease Keywords: Alcoholic liver disease, Fatty liver, Cirrhosis,
More informationNUTRITIONAL OPTIMIZATION IN PRE LIVER TRANSPLANT PATIENTS
NUTRITIONAL OPTIMIZATION IN PRE LIVER TRANSPLANT PATIENTS ACHIEVING NUTRITIONAL ADEQUACY Dr N MURUGAN Consultant Hepatologist Apollo Hospitals Chennai NUTRITION IN LIVER FAILURE extent of problem and consequences
More informationBeta-blockers in cirrhosis: Cons
Beta-blockers in cirrhosis: Cons Eric Trépo MD, PhD Dept. of Gastroenterology. Hepatopancreatology and Digestive Oncology. C.U.B. Hôpital Erasme. Université Libre de Bruxelles. Bruxelles. Belgium Laboratory
More informationProlonged Follow-Up of Patients in the U.S. Multicenter Trial of Ursodeoxycholic Acid for Primary Biliary Cirrhosis
American Journal of Gastroenterology ISSN 0002-9270 C 2004 by Am. Coll. of Gastroenterology doi: 10.1111/j1572-0241.2004.04047.x Published by Blackwell Publishing Prolonged Follow-Up of Patients in the
More informationCurrent Concepts in Diagnosis and Management of Acute Liver Failure
Current Concepts in Diagnosis and Management of Acute Liver Failure Oren Fix, MD, MSc, FACP, AGAF, FAASLD Medical Director, Liver Transplant Program Swedish Medical Center Seattle, WA Learning Objectives
More informationIntradialytic Parenteral Nutrition in Hemodialysis Patients. Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia
Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia Disclosure Information Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Albumin dialysis in cirrhosis with superimposed acute liver injury: possible impact of albumin dialysis on hospitalization costs Hassanein T, Oliver D, Stange J, Steiner C Record Status This is a critical
More informationBack to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
More informationGI bleeding in chronic liver disease
GI bleeding in chronic liver disease Stuart McPherson Consultant Hepatologist Liver Unit, Freeman Hospital, Newcastle upon Tyne and Institute of Cellular Medicine, Newcastle University. Case 54 year old
More informationPACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen
PACT module Acute hepatic failure Intensive Care Training Program Radboud University Medical Centre Nijmegen Acute Liver Failure Acute on Chronic Liver Failure Acute loss of hepatocellular function in
More informationAscites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology
Ascites Management Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH have no relevant
More informationAdrenal Insufficiency in Patients with Liver Cirrhosis and Severe Sepsis: Effect on Survival after Treatment with Hydrocortisone ABSTRACT
20 Original Article Adrenal Insufficiency in Patients with Liver Cirrhosis and Severe Sepsis: Effect on Survival after Treatment with Hydrocortisone Pattanasirigool C Prasongsuksan C Settasin S Letrochawalit
More informationTreatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial
3 Stine JG, et al., 218; 17 (2): 3-36 ORIGINAL ARTICLE March-April, Vol. 17 No. 2, 218: 3-36 The Official Journal of the Mexican Association of Hepatology, the Latin-American Association for Study of the
More information